ELV Elevance Health
FY2025 10-K
Elevance Health (ELV) filed its fiscal year 2025 10-K annual report with the SEC on Feb 6, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.
AI Filing AnalysisFY2025 10-K
Business Overview
- • Core business model: Health benefits and insurance services built significantly through mergers, acquisitions, joint ventures, and strategic alliances
- • Emphasis on risks related to integration and liabilities from recent and future business combinations impacting financials and operations
Management Discussion & Analysis
- • Revenue details and YoY change not disclosed in provided text
- • Operating gain and margin defined but no actual % figures or changes provided
Risk Factors
- • Risk adjustment audits by CMS and HHS OIG awaiting finalization, with potential retroactive payment adjustments impacting financial results
- • Concentration in states like California, NY, Texas, exposed to regional economic downturns affecting enrollment and revenues
Financial SummaryXBRL
Revenue
$199.1B
Net Income
$5.7B
Operating Margin
3.6%
Net Margin
2.8%
ROE
12.9%
Total Assets
$121.5B
EPS (Diluted)
$25.21
Operating Cash Flow
$4.3B
Source: XBRL data from Elevance Health FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on Elevance Health
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.